ID CDS1_RAT Reviewed; 461 AA. AC O35052; A0JPL6; O88208; DT 15-JUL-1998, integrated into UniProtKB/Swiss-Prot. DT 30-MAY-2000, sequence version 2. DT 24-JAN-2024, entry version 149. DE RecName: Full=Phosphatidate cytidylyltransferase 1 {ECO:0000305}; DE EC=2.7.7.41 {ECO:0000269|PubMed:29253589, ECO:0000269|PubMed:30862571, ECO:0000269|PubMed:9083091, ECO:0000269|PubMed:9345289}; DE AltName: Full=CDP-DAG synthase 1; DE AltName: Full=CDP-DG synthase 1; DE AltName: Full=CDP-diacylglycerol synthase 1; DE Short=CDS 1; DE AltName: Full=CDP-diglyceride pyrophosphorylase 1; DE AltName: Full=CDP-diglyceride synthase 1; DE AltName: Full=CTP:phosphatidate cytidylyltransferase 1; GN Name=Cds1 {ECO:0000312|RGD:621185}; Synonyms=Cds; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Rattus. OX NCBI_TaxID=10116; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, ACTIVITY RP REGULATION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND RP BIOPHYSICOCHEMICAL PROPERTIES. RC STRAIN=Wistar; TISSUE=Brain; RX PubMed=9083091; DOI=10.1074/jbc.272.14.9503; RA Saito S., Goto K., Tonosaki A., Kondo H.; RT "Gene cloning and characterization of CDP-diacylglycerol synthase from rat RT brain."; RL J. Biol. Chem. 272:9503-9509(1997). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=Wistar; TISSUE=Brain; RA Hosaka K., Imai H., Nikawa J.; RT "Rat brain CDP-diacylglycerol synthase."; RL Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Liver; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP SUBCELLULAR LOCATION. RX PubMed=6271231; DOI=10.1016/0005-2760(81)90274-5; RA Ballas L.M., Bell R.M.; RT "Topography of glycerolipid synthetic enzymes. Synthesis of RT phosphatidylserine, phosphatidylinositol and glycerolipid intermediates RT occurs on the cytoplasmic surface of rat liver microsomal vesicles."; RL Biochim. Biophys. Acta 665:586-595(1981). RN [5] RP FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, AND COFACTOR. RC TISSUE=Liver; RX PubMed=9345289; DOI=10.1006/bbrc.1997.7422; RA Monaco M.E., Feldman M.; RT "Extraction and stabilization of mammalian CDP-diacylglycerol synthase RT activity."; RL Biochem. Biophys. Res. Commun. 239:166-170(1997). RN [6] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35 AND SER-37, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=22673903; DOI=10.1038/ncomms1871; RA Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C., RA Olsen J.V.; RT "Quantitative maps of protein phosphorylation sites across 14 different rat RT organs and tissues."; RL Nat. Commun. 3:876-876(2012). RN [7] RP FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, AND SUBCELLULAR LOCATION. RX PubMed=29253589; DOI=10.1016/j.bbalip.2017.12.005; RA Blunsom N.J., Gomez-Espinosa E., Ashlin T.G., Cockcroft S.; RT "Mitochondrial CDP-diacylglycerol synthase activity is due to the RT peripheral protein, TAMM41 and not due to the integral membrane protein, RT CDP-diacylglycerol synthase 1."; RL Biochim. Biophys. Acta 1863:284-298(2018). RN [8] RP FUNCTION, CATALYTIC ACTIVITY, AND INDUCTION. RX PubMed=30862571; DOI=10.1016/j.bbalip.2019.03.002; RA Blunsom N.J., Gomez-Espinosa E., Ashlin T.G., Cockcroft S.; RT "Sustained phospholipase C stimulation of H9c2 cardiomyoblasts by RT vasopressin induces an increase in CDP-diacylglycerol synthase 1 (CDS1) RT through protein kinase C and cFos."; RL Biochim. Biophys. Acta 1864:1072-1082(2019). CC -!- FUNCTION: Catalyzes the conversion of phosphatidic acid (PA) to CDP- CC diacylglycerol (CDP-DAG), an essential intermediate in the synthesis of CC phosphatidylglycerol, cardiolipin and phosphatidylinositol CC (PubMed:9083091, PubMed:9345289, PubMed:29253589, PubMed:30862571). CC Exhibits almost no acyl chain preference for PA, showing no CC discrimination for the sn-1/sn-2 acyl chain composition of PAs (By CC similarity). Plays an important role in regulatinng the growth of lipid CC droplets which are storage organelles at the center of lipid and energy CC homeostasis (By similarity). Positively regulates the differentiation CC and development of adipocytes (By similarity). CC {ECO:0000250|UniProtKB:P98191, ECO:0000250|UniProtKB:Q92903, CC ECO:0000269|PubMed:29253589, ECO:0000269|PubMed:30862571, CC ECO:0000269|PubMed:9083091, ECO:0000269|PubMed:9345289}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a 1,2-diacyl-sn-glycero-3-phosphate + CTP + H(+) = a CDP-1,2- CC diacyl-sn-glycerol + diphosphate; Xref=Rhea:RHEA:16229, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, ChEBI:CHEBI:37563, CC ChEBI:CHEBI:58332, ChEBI:CHEBI:58608; EC=2.7.7.41; CC Evidence={ECO:0000269|PubMed:29253589, ECO:0000269|PubMed:30862571, CC ECO:0000269|PubMed:9083091, ECO:0000269|PubMed:9345289}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16230; CC Evidence={ECO:0000305|PubMed:9083091}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero- CC 3-phosphate + CTP + H(+) = 1-octadecanoyl-2-(5Z,8Z,11Z,14Z- CC eicosatetraenoyl)-sn-glycero-3-cytidine-5'-diphosphate + diphosphate; CC Xref=Rhea:RHEA:45648, ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:37563, ChEBI:CHEBI:77091, ChEBI:CHEBI:85349; CC Evidence={ECO:0000250|UniProtKB:Q92903}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45649; CC Evidence={ECO:0000250|UniProtKB:Q92903}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-octadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3- CC phosphate + CTP + H(+) = 1-octadecanoyl-2-(9Z,12Z-octadecadienoyl)- CC sn-glycero-3-cytidine-5'-diphosphate + diphosphate; CC Xref=Rhea:RHEA:45660, ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:37563, ChEBI:CHEBI:77098, ChEBI:CHEBI:85352; CC Evidence={ECO:0000250|UniProtKB:Q92903}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45661; CC Evidence={ECO:0000250|UniProtKB:Q92903}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero- CC 3-phosphate + CTP + H(+) = 1-hexadecanoyl-2-(5Z,8Z,11Z,14Z- CC eicosatetraenoyl)-sn-glycero-3-cytidine-5'-diphosphate + diphosphate; CC Xref=Rhea:RHEA:45652, ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:37563, ChEBI:CHEBI:72864, ChEBI:CHEBI:85350; CC Evidence={ECO:0000250|UniProtKB:Q92903}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45653; CC Evidence={ECO:0000250|UniProtKB:Q92903}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1,2-di-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-3-phosphate CC + CTP + H(+) = 1,2-di-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3- CC cytidine-5'-diphosphate + diphosphate; Xref=Rhea:RHEA:45656, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, ChEBI:CHEBI:37563, CC ChEBI:CHEBI:77126, ChEBI:CHEBI:85351; CC Evidence={ECO:0000250|UniProtKB:Q92903}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45657; CC Evidence={ECO:0000250|UniProtKB:Q92903}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphate + CC CTP + H(+) = 1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3- CC cytidine-5'-diphosphate + diphosphate; Xref=Rhea:RHEA:45664, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, ChEBI:CHEBI:37563, CC ChEBI:CHEBI:74560, ChEBI:CHEBI:85353; CC Evidence={ECO:0000250|UniProtKB:Q92903}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45665; CC Evidence={ECO:0000250|UniProtKB:Q92903}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-octadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn- CC glycero-3-phosphate + CTP + H(+) = 1-octadecanoyl-2- CC (4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-cytidine-5'- CC diphosphate + diphosphate; Xref=Rhea:RHEA:45668, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:37563, ChEBI:CHEBI:77130, CC ChEBI:CHEBI:85354; Evidence={ECO:0000250|UniProtKB:Q92903}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45669; CC Evidence={ECO:0000250|UniProtKB:Q92903}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1,2-di-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphate + CTP + CC H(+) = 1,2-di-(9Z,12Z-octadecadienoyl)-sn-glycero-3-cytidine-5'- CC diphosphate + diphosphate; Xref=Rhea:RHEA:45672, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:37563, ChEBI:CHEBI:77128, CC ChEBI:CHEBI:85355; Evidence={ECO:0000250|UniProtKB:Q92903}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45673; CC Evidence={ECO:0000250|UniProtKB:Q92903}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphate + CTP + H(+) = CC 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-cytidine-5'-diphosphate + CC diphosphate; Xref=Rhea:RHEA:45676, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:37563, ChEBI:CHEBI:74546, CC ChEBI:CHEBI:85356; Evidence={ECO:0000250|UniProtKB:Q92903}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45677; CC Evidence={ECO:0000250|UniProtKB:Q92903}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000269|PubMed:9345289}; CC -!- ACTIVITY REGULATION: Activated by GTP. Inhibited by CDP-diacylglycerol CC and by phosphatidylglycerol 4,5-bisphosphate (PPI2). CC {ECO:0000269|PubMed:9083091, ECO:0000269|PubMed:9345289}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=102 uM for 1-stearoyl-2-arachidonoyl-sn-glycero-3-phosphate CC {ECO:0000269|PubMed:9083091}; CC KM=114 uM for 1,2-dioleoyl-sn-glycero-3-phosphate CC {ECO:0000269|PubMed:9083091}; CC KM=138 uM for phosphatidic acid {ECO:0000269|PubMed:9083091}; CC Vmax=268 pmol/min/mg enzyme for CC 1-stearoyl-2-arachidonoyl-sn-glycero-3-phosphate CC {ECO:0000269|PubMed:9083091}; CC Vmax=259 pmol/min/mg enzyme for 1,2-dioleoyl-sn-glycero-3-phosphate CC {ECO:0000269|PubMed:9083091}; CC Vmax=198 pmol/min/mg enzyme for phosphatidic acid CC {ECO:0000269|PubMed:9083091}; CC -!- PATHWAY: Phospholipid metabolism; CDP-diacylglycerol biosynthesis; CDP- CC diacylglycerol from sn-glycerol 3-phosphate: step 3/3. CC -!- SUBUNIT: Homodimer (PubMed:29253589). Interacts with FOS; this CC interaction may enhance catalytic activity (By similarity). CC {ECO:0000250|UniProtKB:P98191, ECO:0000269|PubMed:29253589}. CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane CC {ECO:0000269|PubMed:29253589, ECO:0000269|PubMed:6271231, CC ECO:0000269|PubMed:9083091}; Multi-pass membrane protein {ECO:0000255}. CC -!- TISSUE SPECIFICITY: Brain, retina and testis. Found in cerebellar CC Purkinje cells, pineal body, inner segment of photoreceptor cells and CC postmitotic spermatocytes and spermatids. {ECO:0000269|PubMed:9083091}. CC -!- SIMILARITY: Belongs to the CDS family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AB000517; BAA22085.1; -; mRNA. DR EMBL; AB009999; BAA28787.1; -; mRNA. DR EMBL; BC127492; AAI27493.1; -; mRNA. DR RefSeq; NP_112521.2; NM_031242.2. DR AlphaFoldDB; O35052; -. DR STRING; 10116.ENSRNOP00000002918; -. DR iPTMnet; O35052; -. DR PhosphoSitePlus; O35052; -. DR PaxDb; 10116-ENSRNOP00000002918; -. DR Ensembl; ENSRNOT00000002918.7; ENSRNOP00000002918.3; ENSRNOG00000002142.7. DR Ensembl; ENSRNOT00055042434; ENSRNOP00055034653; ENSRNOG00055024648. DR Ensembl; ENSRNOT00060016448; ENSRNOP00060012856; ENSRNOG00060009751. DR Ensembl; ENSRNOT00065020331; ENSRNOP00065015629; ENSRNOG00065012493. DR GeneID; 81925; -. DR KEGG; rno:81925; -. DR AGR; RGD:621185; -. DR CTD; 1040; -. DR RGD; 621185; Cds1. DR eggNOG; KOG1440; Eukaryota. DR GeneTree; ENSGT00940000158223; -. DR HOGENOM; CLU_023471_0_1_1; -. DR InParanoid; O35052; -. DR OMA; FFAYMYF; -. DR OrthoDB; 5481516at2759; -. DR PhylomeDB; O35052; -. DR TreeFam; TF313464; -. DR BRENDA; 2.7.7.41; 5301. DR Reactome; R-RNO-1483226; Synthesis of PI. DR UniPathway; UPA00557; UER00614. DR PRO; PR:O35052; -. DR Proteomes; UP000002494; Chromosome 14. DR Bgee; ENSRNOG00000002142; Expressed in duodenum and 19 other cell types or tissues. DR GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD. DR GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:RGD. DR GO; GO:0016020; C:membrane; IDA:UniProtKB. DR GO; GO:0004605; F:phosphatidate cytidylyltransferase activity; IDA:UniProtKB. DR GO; GO:0016024; P:CDP-diacylglycerol biosynthetic process; ISS:UniProtKB. DR GO; GO:0140042; P:lipid droplet formation; ISS:UniProtKB. DR GO; GO:0006661; P:phosphatidylinositol biosynthetic process; ISS:UniProtKB. DR GO; GO:0045600; P:positive regulation of fat cell differentiation; ISS:UniProtKB. DR InterPro; IPR000374; PC_trans. DR InterPro; IPR016720; PC_Trfase_euk. DR PANTHER; PTHR13773; PHOSPHATIDATE CYTIDYLYLTRANSFERASE; 1. DR PANTHER; PTHR13773:SF16; PHOSPHATIDATE CYTIDYLYLTRANSFERASE 1; 1. DR Pfam; PF01148; CTP_transf_1; 1. DR PIRSF; PIRSF018269; PC_trans_euk; 1. DR PROSITE; PS01315; CDS; 1. PE 1: Evidence at protein level; KW Endoplasmic reticulum; Lipid biosynthesis; Lipid metabolism; Magnesium; KW Membrane; Methylation; Nucleotidyltransferase; Phospholipid biosynthesis; KW Phospholipid metabolism; Phosphoprotein; Reference proteome; Transferase; KW Transmembrane; Transmembrane helix. FT CHAIN 1..461 FT /note="Phosphatidate cytidylyltransferase 1" FT /id="PRO_0000090715" FT TRANSMEM 96..116 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 149..169 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 183..203 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 230..250 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 279..299 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 357..377 FT /note="Helical" FT /evidence="ECO:0000255" FT REGION 1..68 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 25..56 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 7 FT /note="Omega-N-methylarginine" FT /evidence="ECO:0000250|UniProtKB:P98191" FT MOD_RES 35 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:22673903" FT MOD_RES 37 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:22673903" FT CONFLICT 172 FT /note="R -> K (in Ref. 2; BAA28787)" FT /evidence="ECO:0000305" FT CONFLICT 299..308 FT /note="SKYQYFVCPV -> VQVSVLCGARW (in Ref. 1; BAA22085)" FT /evidence="ECO:0000305" FT CONFLICT 326 FT /note="L -> V (in Ref. 2; BAA28787)" FT /evidence="ECO:0000305" SQ SEQUENCE 461 AA; 52970 MW; 66061B9A8AF73B3D CRC64; MLELRHRGGC PGPGGAGTPP PREGEAAGGD HETESTSDKE TDIDDRYGDL DARGDSDVPE VPPSSDRTPE ILKKALSGLS SRWKNWWIRG ILTLTMISLF FLIIYMGSFM LMLLVLGIQV KCFQEIITIG YRVYHSYDLP WFRTLSWYFL LCVNYFFYGE TVADYFATFV QREEQLQFLI RYHRFISFAL YLAGFCMFVL SLVKKHYRLQ FYMFAWTHVT LLITVTQSHL VIQNLFEGMI WFLVPISSVI CNDITAYLFG FFFGRTPLIK LSPKKTWEGF IGGFFSTVIF GFIAAYVLSK YQYFVCPVEY RSDVNSFVTE CEPSELFQLQ NYSLPPFLQA VLSRETVSLY PFQIHSIALS TFASLIGPFG GFFASGFKRA FKIKDFANTI PGHGGIMDRF DCQYLMATFV HVYITSFIRG PNPSKVLQQL LVLQPEQQLN IYRTLKIHLT EKGILQPTWK V //